Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
| 351.06 Delayed Data As of Dec 01 |  -3.75 / -1.06%Today’s Change | 282.21 Today|||52-Week Range 387.42 | +21.57% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.0B | 1.7B | 2.5B | 3.0B | |
| Cost of Goods Sold | 62.2M | 149.1M | 213.7M | 337.1M | ||
| Depreciation And Amortization | 62.3M | 61.4M | 61.4M | 72.4M | ||
| Operating Expenses | Gross Income | 907.8M | 1.5B | 2.2B | 2.6B | |
| General Expenses | 1.4B | 1.5B | 1.8B | 2.0B | ||
| Research And Development | 995.9M | 1.0B | 1.3B | 1.4B | ||
| Total Operating Expenses | 1.5B | 1.7B | 2.1B | 2.4B | ||
| Non-Operating Expenses | Operating Income | -464.7M | 11.2M | 397.9M | 665.2M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 807.0K | ||
| Extraordinary Charge | -2.2M | -1.3M | -288.8M | -29.0M | ||
| Interest Expense On Debt | 84.2M | 81.4M | 57.6M | 34.1M | ||
| Other Expenses | -6.7M | 4.1M | -67.3M | -2.7M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -557.8M | -67.4M | -15.7M | 600.2M | |
| Income Taxes | -30.4M | -16.7M | -107.3M | -1.5B | ||
| Minority Interest | -31.8M | -28.0M | -171.8M | -9.8M | ||
| Net Income | -556.3M | -112.1M | 263.2M | 2.1B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 241.3M | 244.7M | 248.9M | 254.3M | |
| Shares To Calculate EPS Diluted | 241.3M | 244.7M | 253.2M | 259.2M | ||
| Earnings Per Share | EPS | -$2.31 | -$0.46 | $1.04 | $8.09 | |
| EPS Diluted | -$2.31 | -$0.46 | $1.04 | $8.09 | ||
